Is desitin.fi Safe? Security Analysis for Desitin Pharma Oy
Check if desitin.fi is a scam or legitimate. Free security scan and reviews.
AI Summary
Desitin Pharma Oy is a pharmaceutical company operating primarily in Finland as part of the Desitin Arzneimittel GmbH group headquartered in Hamburg, Germany. The company specializes in pharmaceutical products including orphan drugs for central nervous system disorders, with a focus on epilepsy and related conditions. Their market position is that of a niche pharmaceutical provider with licensing agreements for orphan drugs across Europe. The website is professionally designed, well-structured, and optimized for SEO and mobile devices, reflecting a medium-sized enterprise with a clear business focus. Technically, the website is built on WordPress using modern frameworks such as Bootstrap and includes SEO and cookie consent plugins. It integrates external services like Google Analytics and Google Maps, and employs a cookie consent mechanism compliant with GDPR. The technical infrastructure is sound with good performance and accessibility, though some security headers could be improved. From a security perspective, the site enforces HTTPS and uses cookie consent to comply with privacy regulations. No critical vulnerabilities or exposed sensitive data were detected. However, the absence of explicit security policies and incident response information suggests room for improvement in transparency and preparedness. The WHOIS data aligns well with the business identity, enhancing trustworthiness. Overall, the website presents a low-risk profile with strong business credibility and compliance posture. Strategic recommendations include enhancing security headers, publishing security policies, and improving incident response visibility to further strengthen trust and security posture.
Detected Technologies
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
Desitin Pharma Oy operates within the healthcare sector, focusing on pharmaceutical product commercialization and orphan drug licensing. The company leverages its parent company Desitin Arzneimittel GmbH's expertise and presence in Germany to serve multiple European markets through localized websites. Their business model centers on licensing and distribution of specialized pharmaceutical products, targeting healthcare professionals and patients with CNS disorders. The presence of multiple country-specific domains indicates a broad partnership ecosystem and international market reach. Growth indicators include recent domain registration and active content updates. The company maintains professional branding consistency and trust signals such as privacy policies and contact transparency.
Extracted Contact Information
Marketing Intelligence Data
Phone Numbers (1)
Physical Addresses (1)
Company Registration
Desitin Arzneimittel GmbH
HRB 4235
Security Posture Analysis
Comprehensive Security Assessment
The website demonstrates a moderate to good security maturity level. HTTPS is enforced, and cookie consent mechanisms are implemented to comply with GDPR. Security headers such as Content Security Policy and X-Frame-Options are not explicitly detected, representing an area for enhancement. No vulnerabilities or exposed sensitive data were found in the analysis. The lack of publicly available security policies or incident response contacts limits transparency and may impact user trust. There is no evidence of vulnerability disclosure programs or security.txt files. Overall, the security posture is adequate for the business type but could benefit from formalized policies and improved header configurations.
Strategic Recommendations
Priority Actions for Security Improvement
Implement Content Security Policy (CSP) and other security headers like X-Frame-Options and X-XSS-Protection to mitigate common web attacks.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
Desitin Pharma Oy
Desitin Pharma Oy is a pharmaceutical company operating in Finland, part of the Desitin Arzneimittel GmbH group based in Hamburg, Germany. The company focuses on pharmaceutical products, including orphan drugs for CNS disorders, and operates internationally with multiple country-specific websites.
good
consistent
Technical Stack
moderate
good
basic
good
Security Assessment
- HTTPS enforced
- Cookie consent mechanism implemented
- No exposed sensitive data found
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is fully accessible with no blocking or WAF challenges.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Missing X-XSS-Protection header
MEDIUMLegacy XSS protection (deprecated but still recommended)
Weak Referrer-Policy configuration
LOWCurrent value: "same-origin"
Sensitive data may be cached
LOWCache-Control header should include "no-store" for sensitive pages
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Cookie Policy found
HIGHGDPR requires clear information about cookie usage
No Cookie Consent Banner found
HIGHGDPR requires explicit consent for non-essential cookies
No Data Protection Officer mentioned
LOWLarge organizations may need to designate a DPO under GDPR
Privacy policy may not be GDPR compliant
MEDIUMPrivacy policy lacks explicit GDPR compliance elements
EU business without adequate privacy measures
CRITICALEU businesses are subject to strict GDPR requirements
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Critical sector without clear security compliance
HIGHDetected sectors: transport, health, digital
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
No DMARC reporting
LOWDMARC aggregate reports not configured
No DKIM record found
MEDIUMDKIM adds cryptographic signatures to emails
No BIMI Record
LOWBIMI displays brand logos in email clients
No MTA-STS Policy
MEDIUMMTA-STS enforces TLS for email delivery
No TLS-RPT Record
LOWTLS-RPT provides reporting for email TLS issues
SPF Details
DMARC Details
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Weak Protocols Supported
HIGHServer supports weak protocols: TLSv1.1
OCSP Stapling Not Enabled
LOWOCSP stapling improves performance and privacy
Certificate Transparency Not Implemented
LOWCertificate is not logged in Certificate Transparency logs
SSL Certificate Expires Within 90 Days
MEDIUMSSL certificate expires in 49 days
Mixed Content Detected
MEDIUM6 resources loaded over insecure HTTP
Partial SSL/TLS Assessment
LOWCompleted 3 of 4 security checks due to time constraints
Protocol Support
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
DNS Records
DNSSEC Status
DNS Performance
SPF Analysis
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
High-Risk Service Exposed: FTP
HIGHPort 21 (FTP) is publicly accessible - FTP - Often unencrypted file transfer
Service Exposed: SSH
MEDIUMPort 22 (SSH) is publicly accessible - SSH - Secure but can be brute-forced
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings